In breast cancer patients receiving adjuvant chemotherapy with cyclophosphamide and doxorubicin, CYP2B6 rs3745274 (CYP2B6*9) was reported to be associated with a poor OS [23]. The gene discussed is CYP2B6; the disease is breast carcinoma.